Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4BC5L | — |
administration of only diluent portion of Hiberix to a patient; administration of only diluent portion of Hiberix to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 6-month-old male patient who received Hib (Hiberix) (batch number 4BC5L, expiry date 14-NOV-2028) for prophylaxis. On 13-FEB-2025, the patient received Hiberix. On 13-FEB-2025, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: administration of only diluent portion of Hiberix to a patient) and inappropriate dose of vaccine administered (Verbatim: administration of only diluent portion of Hiberix to a patient). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date 19-FEB-2025 The reporter reported that administration of only diluent portion of Hiberix to a patient. Patient was administered the diluent of Hiberix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.